SHINEWAY PHARM (02877) · Company profile · Eqvero

SHINEWAY PHARM

02877HKEX

Unit: CNY	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	3.14 bn CNY	3.78 bn CNY	4.52 bn CNY	3.95 bn CNY	3.22 bn CNY
Cost of revenue	798.33 m CNY	877.56 m CNY	945.32 m CNY	826.46 m CNY	630.83 m CNY
Research and development expense	103.1 m CNY	100.52 m CNY	110.46 m CNY	117.45 m CNY	112.71 m CNY
Selling, general and administrative expense	1.45 bn CNY	1.89 bn CNY	2.31 bn CNY	2.1 bn CNY	1.76 bn CNY
Operating profit after depreciation	682.07 m CNY	835.99 m CNY	970.1 m CNY	713.58 m CNY	534.37 m CNY
Operating profit before depreciation	752.95 m CNY	904.73 m CNY	1.15 bn CNY	899.44 m CNY	716.75 m CNY
EBIT	682.07 m CNY	835.99 m CNY	970.1 m CNY	713.58 m CNY	534.37 m CNY
EBITDA	752.95 m CNY	904.73 m CNY	1.15 bn CNY	899.44 m CNY	716.75 m CNY
Interest expense	5.69 m CNY	6.13 m CNY	2.74 m CNY	630 k CNY	1.25 m CNY
Profit before tax	1.27 bn CNY	1.15 bn CNY	1.24 bn CNY	917.03 m CNY	720.1 m CNY
Income tax expense	319.32 m CNY	305.67 m CNY	270.74 m CNY	194.25 m CNY	163.43 m CNY
Income before extraordinary items	949.95 m CNY	840.05 m CNY	969.51 m CNY	722.77 m CNY	556.67 m CNY
Common dividends	355.04 m CNY	407.92 m CNY	317.27 m CNY	241.73 m CNY	294.61 m CNY
Total dividends	355.04 m CNY	407.92 m CNY	317.27 m CNY	241.73 m CNY	294.61 m CNY

Quotes are end-of-day data. Content is for research purposes and is not investment advice.